Nogmaals goed nieuws ivm vaccinatie
Mensen jonger van 50 jaar die een dosis van 50% van het vaccin van Moderna krijgen, lijken even goed beschermd te zijn. Dus nog steeds twee vaccinaties, maar wel slechts 50% van de dosis.
bron NY Times (Slaoui is de leider van operation Warp Speed)
In an interview on the CBS program “Face the Nation,” Dr. Slaoui pointed to data from clinical trials run by Moderna, whose vaccine is typically given in two doses, four weeks apart, each containing 100 micrograms of active ingredient.
In the trials, people between the ages of 18 and 55 who received two half-doses produced an “identical immune response to the 100 microgram dose,” Dr. Slaoui said. The F.D.A. and Moderna are now considering implementing this regimen on a more widespread scale, he added.